Lakshmi A Devi Selected Research

Lakshmi A Devi Research Topics

Disease

24	Pain (Aches) 01/2023 - 03/2006
10	Neuralgia (Stump Neuralgia) 01/2023 - 02/2010
9	Chronic Pain 01/2022 - 04/2004
7	Body Weight (Weight, Body) 01/2019 - 03/2004
6	Hyperalgesia 01/2022 - 10/2011
6	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 04/2008
3	Substance-Related Disorders (Drug Abuse) 01/2019 - 03/2006
2	Obesity 01/2022 - 12/2002
2	Respiratory Insufficiency (Respiratory Failure) 11/2020 - 01/2020
2	Nausea 01/2018 - 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Congenital Pain Insensitivity 01/2022
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2022
1	Diabetes Mellitus 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Autonomic Nervous System Diseases (Dysautonomia) 12/2020
1	Hypersensitivity (Allergy) 01/2020
1	Fibromyalgia (Fibrositis) 10/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2019
1	Sleep Wake Disorders 01/2018
1	Mood Disorders (Mood Disorder) 12/2017
1	Mental Disorders (Mental Disorder) 12/2017
1	Cocaine-Related Disorders (Cocaine Addiction) 05/2016
1	Visceral Pain 05/2016
1	Neoplasms (Cancer) 02/2016
1	Triple Negative Breast Neoplasms 02/2016
1	Diarrhea 12/2014
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2014
1	Fatty Liver 03/2014
1	Acute Pain 03/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2013
1	Schizophrenia (Dementia Praecox) 01/2013

Drug/Important Bio-Agent (IBA)

16	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 04/2004
11	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 03/2006
10	Opioid Analgesics (Opioids)IBA 01/2023 - 02/2010
10	Opiate AlkaloidsIBA 01/2020 - 04/2004
8	Peptides (Polypeptides)IBA 01/2022 - 12/2002
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2006
7	Analgesics (Analgesic Drugs)IBA 01/2022 - 04/2004
5	NeuropeptidesIBA 01/2022 - 03/2004
5	LigandsIBA 08/2019 - 08/2006
3	CannabinoidsIBA 01/2022 - 02/2010
3	hemopressinIBA 01/2022 - 12/2007
3	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020 - 04/2012
3	delta Opioid Receptors (delta Opioid Receptor)IBA 08/2019 - 04/2004
3	Neuropeptide Receptors (Neuropeptide Receptor)IBA 01/2019 - 12/2017
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2014 - 01/2012
2	EnzymesIBA 01/2022 - 12/2002
2	Opioid Peptides (Opioid Peptide)IBA 01/2020 - 12/2002
2	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2019 - 10/2008
2	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 08/2019 - 02/2012
2	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 06/2010
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2010 - 10/2008
1	Pain-FreeIBA 01/2023
1	Cre recombinaseIBA 01/2023
1	Prolyl OligopeptidasesIBA 01/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	EndocannabinoidsIBA 01/2022
1	3-(2-carboxyindol-3-yl)propionic acidIBA 01/2022
1	Muscarinic M3 ReceptorIBA 12/2020
1	AutoantibodiesIBA 12/2020
1	Cholinergic Agents (Cholinergics)IBA 12/2020
1	Cholinergic ReceptorsIBA 12/2020
1	Synthetic DrugsIBA 01/2020
1	CYM51010IBA 01/2020
1	ORALIT (ORS)IBA 01/2020
1	HU 211 (HU 210)IBA 08/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2019
1	Transient Receptor Potential ChannelsIBA 10/2018
1	Triglycerides (Triacylglycerol)IBA 11/2017
1	CholesterolIBA 11/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 05/2016
1	Protein Kinase CIBA 02/2016
1	Estrogen ReceptorsIBA 02/2016
1	MS0015203IBA 01/2016
1	UbiquitinIBA 10/2015
1	Loperamide (Imodium)FDA LinkGeneric 12/2014
1	eluxadolineIBA 12/2014
1	Castor Oil (Oil, Castor)IBA 12/2014
1	Yohimbine (Yocon)IBA 06/2014
1	Methysergide (Sansert)FDA Link 06/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 06/2014
1	Indole AlkaloidsIBA 03/2014
1	mitragynineIBA 03/2014
1	naltrindoleIBA 03/2014
1	methyl 2- (3- ethyl- 9- fluoro- 7a- hydroxy- 8- methoxy- 1,2,3,4,6,7,7a,12,12a,12b- decahydroindolo(2,3- a)quinolizin- 2- yl)- 3- methoxyacrylateIBA 03/2014
1	CannabidiolIBA 03/2014
1	7-hydroxymitragynineIBA 03/2014
1	GhrelinIBA 10/2013
1	Neuropeptide YIBA 10/2013
1	LeptinIBA 10/2013
1	EndorphinsIBA 07/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	D-Penicillamine (2,5)- EnkephalinIBA 02/2012

Therapy/Procedure

7	Therapeutics 11/2020 - 04/2004
5	Analgesia 01/2022 - 02/2010
2	Drug Therapy (Chemotherapy) 08/2019 - 02/2010
2	Oral Administration 11/2017 - 06/2014
1	Glycemic Control 01/2022
1	Subcutaneous Injections 01/2020